- Home
- SRPT
as 07-04-2025 12:36pm EST
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
| Founded: | 1980 | Country: | United States |
| Employees: | 1372 | City: | CAMBRIDGE |
| Market Cap: | 1.7B | IPO Year: | 1997 |
| Target Price: | $64.00 | AVG Volume (30 days): | 7.9M |
| Analyst Decision: | Buy | Number of Analysts: | 25 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.59 | EPS Growth: | N/A |
| 52 Week Low/High: | $16.88 - $155.95 | Next Earning Date: | 08-06-2025 |
| Revenue: | $2,233,371,000 | Revenue Growth: | 59.15% |
| Revenue Growth (this year): | 26.87% | Revenue Growth (next year): | 3.15% |
Latest Sarepta Therapeutics Inc. (DE) News
SRPT Breaking Stock News: Dive into SRPT Ticker-Specific Updates for Smart Investing
Motley Fool
8 days ago
2 Beaten-Down Stocks to Avoid
Simply Wall St.
9 days ago
Sarepta Therapeutics (NasdaqGS:SRPT) Faces Shipment Suspension Amid Safety Update
Investor's Business Daily
10 days ago
Sarepta Therapeutics Is Already Down 86% This Year. And The Other Shoe Just Dropped.
Insider Monkey
10 days ago
TD Cowen Downgrades Sarepta Therapeutics (SRPT) Stock to Hold, Reduces PT
MT Newswires
10 days ago
Sarepta Therapeutics' Elevidys Under Investigation by US FDA Following Patient Deaths
Argus Research
11 days ago
SRPT: Lowering target price to $15.00
Insider Monkey
11 days ago
Sarepta Viral Vector Gets FDA Platform Technology Designation
Insider Monkey
11 days ago
Sarepta Therapeutics (SRPT) Tumbles 44% W/W as Analyst Cuts Price Target by 63%
Compare SRPT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SRPT Sarepta Therapeutics Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.